Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability. (2019)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11657-019-0564-7
PubMed Identifier: 30719589
Publication URI: http://europepmc.org/abstract/MED/30719589
Type: Journal Article/Review
Volume: 14
Parent Publication: Archives of osteoporosis
Issue: 1